SL
LLY icon

Sentry LLC’s Eli Lilly LLY Stock Holding History

Sentry LLC’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.02M Buy
5,020
+8
+0.2% +$8.17K 1.68% 12
2026
Q1 		$4.61M Hold
5,012
– – 1.47% 13
2025
Q4 		$5.39M Hold
5,012
– – 1.47% 11
2025
Q3 		$3.82M Buy
5,012
+7
+0.1% +$5.21K 0.95% 17
2025
Q2 		$3.9M Hold
5,005
– – 0.78% 17
2025
Q1 		$4.13M Buy
5,005
+1
+0% +$832 0.8% 15
2024
Q4 		$3.86M Sell
5,004
-1
-0% -$828 0.75% 15
2024
Q3 		$4.43M Buy
5,005
+1
+0% +$899 0.85% 15
2024
Q2 		$4.53M Sell
5,004
-1
-0% -$800 0.83% 14
2024
Q1 		$3.89M Sell
5,005
-2
-0% -$1.42K 0.73% 15
2023
Q4 		$2.92M Buy
5,007
+2
+0% +$1.17K 0.62% 17
2023
Q3 		$2.69M Hold
5,005
– – 0.57% 18
2023
Q2 		$2.35M Hold
5,005
– – 0.51% 18
2023
Q1 		$1.72M Buy
+5,005
New +$1.69M 0.4% 19

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sentry LLC's LLY Position: Q2 2026 in Review

Sentry LLC increased its Eli Lilly (LLY) stake by 0.16% in Q2 2026, buying an estimated $8.17K and bringing the position to 5,020 shares worth $6.02M. The position accounts for 1.68% of the portfolio, ranked #12.

Sentry LLC first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Sentry LLC held 5,020 shares of Eli Lilly worth $6.02M as of Q2 2026.
  • Sentry LLC bought 8 Eli Lilly shares in Q2 2026, an estimated $8.17K.
  • Eli Lilly made up 1.68% of Sentry LLC's portfolio in Q2 2026, its #12 holding.
  • Sentry LLC first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Sentry LLC's 13F filing for Q2 2026, filed 14 Aug 2026.